Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial
Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.5 is now shown, replacing v3.5.4. This indicates a minor platform update with no changes to the study data or main page content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added to the page, replacing Revision: v3.5.3. This indicates a newer build/version of the page, with no apparent changes to the study details.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a release update rather than a change to the study information presented.SummaryDifference0.0%

- Check55 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No substantive changes to trial details or core content are evident.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.